Trichuris suis ova
Sponsors
Rigshospitalet, Denmark, Montefiore Medical Center, Charite University, Berlin, Germany, NYU Langone Health, Coronado Biosciences, Inc.
Conditions
AutismCrohn's DiseaseMultiple SclerosisPlaque PsoriasisPsoriasisRelapsing Multiple SclerosisUlcerative ColitisUlcerative Colitis Chronic Moderate
Phase 1
Trichuris Suis Ova in Autism Spectrum Disorders
CompletedNCT01040221
Start: 2012-11-30End: 2014-07-31Updated: 2018-04-03
Safety and Tolerability of Single Doses Oral CNDO 201 Trichuris Suis Ova in Patients With Crohn's Disease
CompletedNCT01434693
Start: 2011-11-30End: 2012-09-30Updated: 2013-05-20
Efficacy Study of Trichuris Suis Ova to Treat Chronic Plaque Psoriasis
TerminatedNCT01948271
Start: 2013-07-31End: 2014-09-30Updated: 2016-09-15
Phase 2
Trichuris Suis Ova Therapy for Relapsing Multiple Sclerosis - a Safety Study
CompletedNCT01006941
Start: 2010-05-31End: 2011-09-30Updated: 2011-11-10
Trichuris Suis Ova (TSO)in Recurrent Remittent Multiple Sclerosis and Clinically Isolated Syndrome
TerminatedNCT01413243
Start: 2012-09-30End: 2017-06-30Target: 50Updated: 2016-05-06
TSO for Plaque Psoriasis
WithdrawnNCT02011269
Start: 2014-03-31Updated: 2015-05-06
Efficacy and Safety of Trichuris Suis Ova (TSO) as Compared to Placebo in Autism Spectrum Disorder
TerminatedNCT02140112
Start: 2014-05-31End: 2015-04-30Updated: 2015-11-04
Probiotic Treatment of Ulcerative Colitis With Trichuris Suis Ova (TSO)
CompletedNCT03565939
Start: 2018-05-04End: 2022-01-10Updated: 2022-04-22